These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33901594)

  • 1. Allogeneic hematopoietic cell transplant overcomes the poor prognostic value of CDKN2 deletion in adult B-lineage acute lymphoblastic leukemia.
    Ling Y; Xu N; Zhao K; Han L; Zhang Q; Fan Z; Huang F; Chen Z; Xuan L; Liu H; Xu J; Chen X; Yu S; Zhou H; Sun J; Liu Q
    Cancer Lett; 2021 Jul; 510():59-66. PubMed ID: 33901594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic haematopoietic stem cell transplantation might overcome the poor prognosis of adolescents and adult patients with T-lineage acute lymphoblastic leukaemia and CDKN2 deletion.
    Hu X; Wang Z; Qin Y; Xu J; Xu N; Wang Q; Lin R; Zhao K; Zhou H; Xuan L; Yu S; Liu Q
    Bone Marrow Transplant; 2024 Aug; 59(8):1146-1153. PubMed ID: 38769349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia.
    Wang Y; Chen G; Cao R; Li J; He L; Guo X; Liang J; Shi P; Zhou Y; Xu B
    Pharmacogenomics; 2017 Jan; 18(1):77-84. PubMed ID: 27967319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients.
    Xu N; Li YL; Zhou X; Cao R; Li H; Lu QS; Li L; Lu ZY; Huang JX; Sun J; Liu QF; Du QF; Liu XL
    J Cancer; 2015; 6(11):1114-20. PubMed ID: 26516359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.
    Wieduwilt MJ; Stock W; Advani A; Luger S; Larson RA; Tallman M; Appelbaum F; Zhang MJ; Bo-Subait K; Wang HL; Bhatt VR; Dholaria B; Eapen M; Hamadani M; Jamy O; Prestidge T; Pulsipher M; Ritchie D; Rizzieri D; Sharma A; Barba P; Sandmaier BM; de Lima M; Kebriaei P; Litzow M; Saber W; Weisdorf D
    Leukemia; 2021 Jul; 35(7):2076-2085. PubMed ID: 33785862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions.
    Ortí G; Sanz J; García-Cadenas I; Sánchez-Ortega I; Alonso L; Jiménez MJ; Sisinni L; Azqueta C; Salamero O; Badell I; Ferra C; de Heredia CD; Parody R; Sanz MA; Sierra J; Piñana JL; Querol S; Valcárcel D
    Exp Hematol; 2018 Jun; 62():24-32. PubMed ID: 29526774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.
    Hamilton BK; Rybicki L; Abounader D; Adekola K; Advani A; Aldoss I; Bachanova V; Bashey A; Brown S; DeLima M; Devine S; Flowers CR; Ganguly S; Jagasia M; Kennedy VE; Kim DDH; McGuirk J; Pullarkat V; Romee R; Sandhu K; Smith M; Ueda M; Viswabandya A; Vu K; Wall S; Zeichner SB; Perales MA; Majhail NS
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1117-1121. PubMed ID: 28396160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up].
    Bao YS; Jiang EL; Wang M; Wang H; Huang Y; Wei JL; Yang DL; Feng SZ; Qiu LG; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1325-9. PubMed ID: 19099637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation.
    Abdelaty MM; Gawaly A; Fathy GM; Kabbash I; Taha A
    J Egypt Natl Canc Inst; 2020 Jun; 32(1):28. PubMed ID: 32537680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival.
    Logan AC; Vashi N; Faham M; Carlton V; Kong K; Buño I; Zheng J; Moorhead M; Klinger M; Zhang B; Waqar A; Zehnder JL; Miklos DB
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1307-13. PubMed ID: 24769317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
    Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
    Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Dholaria B; Finke J; Brecht A; Schanz U; Niittyvuopio R; Neubauer A; Bornhäuser M; Santarone S; Beelen D; Shimoni A; Rösler W; Giebel S; Savani BN; Mohty M
    Br J Haematol; 2019 Sep; 186(5):767-776. PubMed ID: 31115916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.
    Fang J; Zhang R; Wang H; Hong M; Wu Q; Nie D; You Y; Zhong Z; Li W; Hu Y; Xia L
    Leuk Res; 2016 Jul; 46():61-8. PubMed ID: 27131062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes.
    Alhashim N; Aljurf M; Hassanein M; Chaudhri N; Hashmi S; El-Gohary G; Alsharif F; Alsermani M; Alhumaid M; Beihany AA; Shaheen M; Hanbali A; Alfraih F; Mohamed S; Alzahrani H; Elhassan T; Eldali A; Rasheed W; Ahmed S; Almohareb F; El Fakih R
    Bone Marrow Transplant; 2018 Jul; 53(7):838-843. PubMed ID: 29371685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Yasuda S; Najima Y; Konishi T; Yamada Y; Nagata A; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Shingai N; Yoshioka K; Inamoto K; Mukae J; Toya T; Igarashi A; Shimizu H; Kobayashi T; Kakihana K; Sakamaki H; Kawamata N; Ohashi K; Doki N
    Leuk Res; 2021 Sep; 108():106627. PubMed ID: 34062327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.